Replies to post #170000 on Anavex Life Sciences Corp (AVXL)

[Amatuer17]

The DZP vs A2-73 is an interesting discussion.

Seems DZP has higher binding affinity than A2-73 - so DZP naive patients can have better binding.

Does better binding means better concentration?

Can company do a simple test in few healthy patients to see the concentration level for DZP and DZP naive patients. That will settle the matter.

But if is DZP naive has better effectivity, AVXL does not patent for just A2-73